Liu Liang Chiu-Chu Sara

Director Liu Liang Chiu-Chu Sara sold 200,000 shares of SMCI at $60.00 for $12,000,000 on 2025-07-28

Director Liu sold 200,000 shares at $60.00 while SMCI trades at $60.71, just 14.8% below its 52-week high of $71.22. The sale follows a 23.9% surge in the 30-day period and an 85.5% rally over 90 days, reducing her holdings from 40.63M to 40.43M shares (a 0.5% reduction). Her cross-ticker track record shows 5 prior sells with a well-timed rate of 100.00%, and at SMCI specifically, 2 of 2 measurable prior sells generated negative 90-day returns (-31.7% and -88.6%), suggesting a pattern of selling before declines. However, the most recent SMCI sale on 2025-06-18 was followed by a +15.0% 30-day return, indicating variable timing outcomes. The company posted $4.6B revenue with +110.4% annual growth and net income of $108.8M, but the P/E of 31.46 reflects elevated valuation relative to historical and peer multiples.

Director Liu Liang Chiu-Chu Sara sold 300,000 shares of SMCI at $45.00 for $13,500,000; price -50.7% from 52-week high of $92.00.

Director Liu sold 300,000 shares at $45.00 on June 18, 2025, representing a 0.4% reduction in holdings but a substantial absolute value of $13.5M. The transaction occurred with SMCI trading significantly below its 52-week high of $92.00, though the stock has recovered +8.8% over 30 days and +7.5% over 90 days from that sell point. Examining Liu's track record at SMCI specifically, prior sells on February 26, 2025 and December 5, 2023 were both well-timed at the 90-day mark (posting -17.1% and -57.4% returns respectively), establishing a historical pattern of selling before declines at this ticker. The company's fundamentals show strong revenue growth at +110.4% annually and recent quarterly revenue of $4.6B, though recent sales at lower prices ($45.00 vs. the prior $92.00 high) may reflect valuation reassessment rather than company deterioration.

Director Liu Liang Chiu-Chu Sara sold 200,000 shares (200.0K) for $9,004,621.66 at SMCI on 2025-05-14.

Director Liu Liang Chiu-Chu Sara executed 2 separate sales totaling 200,000 shares for $9,004,621.66 at a blended average price of $45.02, reducing her holdings from 67,403,640 shares to 67,203,640 shares (a -0.3% reduction). The sale occurred when the stock was trading 51.5% below its 52-week high of $95.24 and amid strong recent momentum (30-day return of +44.7%), suggesting the sale was not driven by near-term price weakness. Her cross-ticker track record shows 2 prior sells with a 100.00% well-timed rate at the 90-day mark (average 90d return -57.4%), and her prior sales at SMCI (2025-02-26 and 2023-12-05) also exhibited negative 90-day returns, indicating a pattern of exiting ahead of subsequent declines. SMCI's fundamentals remain robust with annual revenue growth of +110.4%, net income of $108,777,000.00, and a P/E of 23.91, suggesting the sale reflects portfolio positioning rather than fundamental deterioration.

Director Liu Liang Chiu-Chu Sara sells entire 46.3K share position in SMCI for $2.3M at $50.17 as stock trades -65.1% from 52-week high

Liu Liang Chiu-Chu Sara liquidated 46,293 shares of her full position on 2025-02-26 at $50.17, generating $2,322,566.10 in proceeds. The sale occurred at a price 49.1% above the 30-day average but approximately 58% below the 52-week high of $118.81, after the stock had declined materially from its peak. Her prior sell at SMCI on 2023-12-05 was well-timed at the 90-day mark (the stock fell -57.4% afterward), establishing a precedent of her sales preceding downward moves at this ticker. The current price of $41.46 is 17.4% below her transaction price, indicating the stock has continued to decline post-transaction. This complete exit of holdings—combined with her track record of sells that precede declining price action—occurs against a backdrop of fundamentally strong financials: SMCI reported $5.7B quarterly revenue with 110.4% annual growth and a P/E of 17.06, suggesting the sale reflects capital deployment choices rather than deteriorating company fundamentals.